CVRX

CVRx, Inc.

15.31

Top Statistics
Market Cap 371 M Forward PE -7.16 Revenue Growth 27.20 %
Current Ratio 11.32 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -123.75 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -5.52 Enterprise / Revenue 6.81 Price To Sales Trailing12 Months 7.86
Profitability
Profit Margins -123.75 % Operating Margins -97.29 %
Balance Sheet
Total Cash 100 M Total Cash Per Share 4.13 Total Debt 50 M
Total Debt To Equity 77.38 Current Ratio 11.32 Book Value Per Share 2.69
All Measures
Short Ratio 446.00 % Message Board Id finmb_1380491 Fax 763 416 2841
Shares Short Prior Month 2 M Return On Equity -0.7902 City Minneapolis
Uuid 18e77560-d0bd-3e3c-99c4-c943c8d9d9cc Previous Close 15.30 First Trade Date Epoch Utc 1 B
Book Value 2.69 Beta 1.11 Total Debt 50 M
Volume 150139 Price To Book 5.69 Fifty Two Week Low 6.40
Total Cash Per Share 4.13 Total Revenue 47 M Shares Short Previous Month Date 1 B
Target Median Price 16.50 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -97.29 % Target Mean Price 16.50 Net Income To Common -58477000
Short Percent Of Float 0.1302 Implied Shares Outstanding 24 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 217400 Average Volume10days 217400
Total Cash 100 M Next Fiscal Year End 1 B Revenue Per Share 2.19
Held Percent Insiders 0.0440 Ebitda Margins -123.39 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 15.30
Target Low Price 13.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 11.32
Open 15.30 Free Cashflow -21401124 State MN
Dividend Yield 0.00 % Return On Assets -0.3144 Time Zone Short Name EST
Trailing Eps -2.69 Day Low 14.90 Address1 9201 West Broadway Avenue
Shares Outstanding 24 M Price Hint 2 Target High Price 20.00
Website https://www.cvrx.com 52 Week Change -0.2521 Average Volume 300689
Forward Eps -2.14 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 997.50 % Is_sp_500 False Regular Market Day High 15.67
Profit Margins -123.75 % Debt To Equity 77.38 Fifty Two Week High 33.13
Day High 15.67 Shares Short 2 M Regular Market Open 15.30
Industry Key medical-devices Earnings Growth 0.00 % Enterprise To Revenue 6.81
Revenue Growth 27.20 % Shares Percent Shares Out 0.0849 Operating Cashflow -38975000
Currency USD Time Zone Full Name America/New_York Market Cap 371 M
Is_nasdaq_100 False Zip 55445 Quote Type EQUITY
Industry Medical Devices Long Name CVRx, Inc. Regular Market Day Low 14.90
Held Percent Institutions 0.7194 Current Price 15.31 Address2 Suite 650
Enterprise To Ebitda -5.52 Financial Currency USD Current Ratio 11.32
Gross Margins 84.17 % Industry Disp Medical Devices Number Of Analyst Opinions 6
Country United States Float Shares 14 M Two Hundred Day Average 12.23
Enterprise Value 321 M Price To Sales Trailing12 Months 7.86 Forward PE -7.16
Regular Market Volume 150139 Ebitda -58307000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.

The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure.

It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally.

The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.